In 1998, the German Environmental Survey (GerES III) recruited approximately 5000 adults between the ages of 18 and 69 years. The study population for these analyses consisted of 1580 smokers (34% of the total population) and 3126 nonsmokers. Nicotine and cotinine concentrations in urine were determined by HPLC methods with UV-detection and corrected for creatinine. Nicotine and cotinine concentrations differed between smokers and nonsmokers by factors of 10-100. The multiple linear regression models used for the analyses of nicotine detection in the urine of smokers explained 43.2% and 42.3% of the total volume-specific and creatinine-specific variances, respectively. Cigarette smoking was the major factor responsible for 41% of the total variance. The explained variances of the cotinine results were larger, 51.0% and 49.3% of the total variance were volume-specific and creatinine-specific, respectively. More than 20% of nonsmokers in GerES III were exposed to environmental tobacco smoke at home, at work or in other places. The logistic regression analysis approach used for the group of nonsmokers showed the greatest effects for those exposed to tobacco smoke at home (adjusted OR varied between 4 and 6). These results were seen for nicotine as well as for cotinine excretion. Exposure to tobacco smoke in the workplace doubled the risk for the detection of nicotine and cotinine in urine. When other risk factors such as age, sex, social status, community size, season of urine collection, and the consumption of food containing nicotine such as potatoes, cabbage, tea were included, the effect estimates for tobacco smoke exposure remained unchanged. A new federal bill to diminish environmental tobacco smoke (ETS) exposure in the workplace was recently passed in Germany, but protection of nonsmokers from smoking family members at home needs more attention.
Introduction
Recent studies and meta-analyses on the effects of environmental tobacco smoke (ETS) exposure have increased the effect estimates for lung cancer (Boffetta et al., 1998; Jo¨ckel et al., 1998; Kreuzer et al., 2000) . ETS causes irreversible damage to children's airways and has detrimental effects on fetal development, newborns, and respiratory health in adults (US-EPA, 1992; California EPA, 1997; Gold et al., 1996; Janson et al., 2001 ) and increases the risk for cardiovascular disease in adulthood (Hense, 1994) . Since 34% of the total German population aged 18-69 years are active smokers (Becker et al., 2003) , exposure to ETS is an important public health issue in Germany. Nicotine and its metabolite cotinine in urine (and serum) are considered valid biomarkers with high specifity to identify exposure to ETS within 8 h for nicotine and 20-40 h for cotinine (US-EPA, 1992; Benowitz, 1996; Leong et al., 1998) . There is an ongoing controversial debate on other factors that might also affect excretion of nicotine and cotinine in urine and which tends to down play the results about a valid assessment of ETS exposure by these biomarker analyses and the health consequences (Domino et al., 1993; Domino, 1995) . With the exception of crude descriptive data on ETS and its biomarkers (Krause et al., 1998; Becker et al., 2003) , there have been no data published which have systematically analysed nicotine and cotinine concentrations in urine and determined the effect size of main exposure by multivariate modeling with a thorough evaluation of influential factors other than smoking.
Therefore, this paper analyzes factors affecting excretion of nicotine and cotinine in urine and determines whether sources other than tobacco smoke might contribute to nicotine and cotinine concentration in urine using data from a random sample of the German adult population.
Methods

Study Design
The German Environmental Survey (GerES III) was conducted in combination with the National Health Survey (conducted by the Robert-Koch Institute, Berlin) and was a cross-sectional study designed to determine the exposure to contaminants in the German population (www.Umweltbundesamt.de/survey-e/index.htm). In the present study, the association between questionnaire-derived data on active smoking and exposure to ETS at various places such as at home, in the work place and other potential exposures and biomarkers in urine was investigated.
Study Population
During 1997-1999 the population of the (GerES III 1998) was randomly selected from the participants in the German National Health Interview and Examination Survey of adults (Bellach et al., 1998; Thefeld et al., 1999) . The sample was representative of the total population with regard to age (18-69 years), gender, community size, and East-West region (Becker et al., 2003) . Methods and population selection are described in detail elsewhere (Becker et al., 2003) . The participation rate was 54.5% which yielded a total of 4822 participating subjects.
In all, 116 subjects aged 17 years or not having biomarker data were excluded from analyses. Thus, the study population for these analyses consisted of 1580 current smokers (regular or occasional smokers) and 3126 nonsmokers (former smokers or never smokers) with complete data (98% of the original study participants). Complete data including confounding factors is available from 1547 current smokers and 2985 nonsmokers, which were used for multivariate analyses.
Smoking Data and Questionnaire-based Data
Questions on smoking, exposure to ETS at home, in the workplace or elsewhere, and other potential determinants of the biomarker concentration were collected using a selfadministered questionnaire. Current smoking was defined as the regular smoking of at least one cigarette, or one cigar, or one pipe per day or as self-reported occasional smoking.
Dietary information was gathered from a food frequency questionnaire (FFQ, Bellach et al., 1998) and a dietary history (in a subsample of 2960 subjects) (Mensink et al., 1998) .
Urine Collection and Chemical Analyses
Morning urine was collected and frozen until analysis. For the nicotine and cotinine measurements, an internal standard (N-Ethylene-Norcotinine) was added to the urine samples and then they were extracted with methylene chloride and reextracted with sulphuric acid (0.1 ml). Then the extracts were buffered with sodium acetate and measured by an RP-HPLC method with UV-detection (Merkel, 1992) . In addition, in some cases the HPLC-extracts were re-extracted in ethyl acetate and measured by GC/MS. The limits of detection were 2 mg/l for nicotine and 4 mg/l for cotinine. Urinary levels of nicotine and cotinine were corrected for creatinine. Creatinine was measured by autoanalyzer using an enzymatic colour reaction.
Statistical Analyses
All analyses were stratified for smokers and nonsmokers. Levels below the limit of detection were imputed with 0.5 Â LOD. Since the biomarkers were not normally distributed we used geometric means as averages. These analyses did not adjust for the weighted sampling strategy. Therefore, numbers reported here might be different from previous publications (Becker et al., 2003) . Standard multiple regression analysis techniques were applied: linear regression analyses for smoker models and logistic regression analyses for the nonsmoker models, since approximately only 20% of the nonsmoking subpopulation showed detectable nicotine or cotinine concentrations. Linear regression (smoker model) for log-normally distributed response variables (eg., nicotine and cotinine concentration) were performed with natural log (ln) transformed values. For categorical independent variables, such as categorized numbers of cigarettes, cigars or pipes (see Table 3 ) we calculated means ratios (MR) as effect measures with 95% confidence intervals (CI). The means ratio represents the ratio of the geometric mean in the category of study versus a reference category. For the nonsmokers, we calculated logistic regression models for detectable nicotine and cotinine. The results were expressed as odds ratios (OR) with 95% confidence interval (CI). We included stepwise other factors of interest to the model in order to study changing effect estimates. Nicotine and cotinine levels in urine were adjusted for creatinine. An additional analysis was performed using crude nicotine and cotinine levels and including creatinine as an independent variable in the model. The statistical software package SAS 8.0 (Cary, NC, USA) was used.
Results Table 1 displayed characteristics of the study population stratified in smokers and nonsmokers. Average nicotine and cotinine concentrations differed between smokers (GM (95% CI), 367 (332-406) mg/l and 856 (787-930) mg/l, respectively) and nonsmokers (GM (95% CI): 1.7 (1.6-1.8) mg/l and 3.2 (3.1-3.3) mg/l, respectively) by two orders of magnitude (Table 2) . Furthermore, Table 2 shows crude average concentrations of these biomarkers for various subgroups of the smoking and nonsmoking subpopulations.
Smoker Models
The multivariate regression model used for the analyses of urinary nicotine explained 43.2% and 42.3% of the total volume-specific and creatinine-specific variance, respectively. Cigarette smoke was the major factor responsible for 41% of the total variance. The models used for urinary cotinine explained 51.0% and 49.3% of the volume-specific and creatinine-specific variance, respectively. Strong associations between number of cigarettes smoked daily and nicotine and cotinine excretion were found (Table 3) . Smoking of cigars (n ¼ 34) and pipes (n ¼ 30) also significantly increased the excretion of nicotine and cotinine in urine (Table 3) . Inclusion of ETS exposure to the smoker model did not show any statistically significant additional effects (data not shown).
Nonsmoker Models
The prevalence of nonsmokers was 66% (n ¼ 2985) in which 44% were never smokers and 22% were former smokers. Strong statistically significant effects on nicotine and cotinine excretion were found for exposure at home (more than one smoker at home, one smoker at home versus a no-smoking household: GM 6.17 (4.07-9.33), 4.06 (3.26-5.06) for volume specific nicotine and GM 5.25 (3.49-7.90), 3.98 (3.21-4.93) for volume-specific cotinine, for workplace exposure (ETS in the workplace: yes versus no): GM 1.89 (1.52-2.35) for nicotine and 2.06 (1.67-2.55) for cotinine, and for exposure elsewhere: GM 1.32 (1.08-1.62) for nicotine and 1.32 (1.08-1.61) for cotinine) ( Table 4 ). In particular, exposure to workplace ETS doubled the risk for detectable excretion of nicotine and cotinine. Several other factors were significantly associated with lower biomarker levels: female versus male, increased age versus age group of 18-29 years, upper versus lower social class, season of urine sampling (summer versus winter period), and lower creatinine levels versus higher (data not shown). The effect estimates from the model using creatinine-adjusted biomarker values were similar to those from the model using the crude biomarker values with the additional independent creatinine variable.
Stratified analyses for never smokers (n ¼ 2001) and former smokers (n ¼ 971) showed slightly increased effect estimates for ETS at home and in the workplace in never smoking subjects (OR 6.68 versus 5.18 to ETS at home and 2.07 versus 1.76 for ETS at workplace) for nicotine. For cotinine, these differences were less pronounced for ETS at home (OR 5.13 versus 5.29), but remained for ETS in the workplace (2.31 versus 1.87).
Since some current smokers might be misclassified as nonsmokers because they self-reported as nonsmokers, sensitivity analyses were also conducted to evaluate the potential effect of this misclassification. Therefore, we excluded subjects with extremely high levels of nicotine and cotinine excretion (above 99th percentile of nicotine or cotinine, n ¼ 38) from the analyses. However, the effect estimates changed only marginally (data not shown).
Dietary Influences
We thoroughly analysed the effect of the consumption of nicotine-containing food on nicotine and cotinine excretion. First, we looked at changes of the effect estimates for ETS exposure at home and in the workplace when intake of nicotine containing food such as tea, potatoes, and cabbage were added stepwise to the model. The effect estimates were changed only marginally if nicotine containing food was added to the model (data not shown). We also performed a sensitivity analysis of a subpopulation of nonsmoking subjects not exposed to ETS. In these 1035 nonsmoking and non-ETS exposed subjects, no statistically significant effects for consumption of tea, potatoes, and cabbage on nicotine and cotinine excretion in urine were found (data not shown).
Discussion
This project analysed factors influencing the excretion of nicotine and cotinine in urine using data from a random sample of the large population-based 1998 GerES III. Nicotine and cotinine concentrations differed between smokers and nonsmokers by two orders of magnitude. Approximately 20% of the nonsmokers were exposed to ETS at home, in the work place or in other places when ETS exposure was defined as excretion of nicotine or cotinine in urine. In active smokers (n ¼ 1547), the total variance of nicotine and cotinine excretion is mainly explained by cigarette smoking (41% out of a total of 43% explained variance LOD -Limit of detection for nicotine (2 mg/l), for cotinine (4 mg/l), for calculations of geometric means (GM), values below the LOD were set to 0.5 Â LOD. Adjusted for gender, age, location, creatinine and additionally mutually adjusted for numbers of daily smoked cigarettes, cigars and pipes, respectively.
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ETS at home (adjusted OR varies between 4 and 6), and ETS exposure in the workplace (adjusted OR was approximately 2) showed a substantial contribution to the concentrations of the investigated biomarkers. Further inclusion of intake of nicotine containing food such as tea, cabbage, potatoes did not show any associations with the biomarkers. The high levels of these biomarkers in winter might be interpreted as a consequence of a higher ETS exposure because people spent probably a longer time indoors and the rooms are not as well ventilated during the cold season.
Measurements of nicotine-related biomarkers have often been used to validate questionnaire-derived data on smoking and exposure to ETS (Patrick et al., 1994) . However, systematic multivariate modelling of potential factors influencing these biomarkers including estimation of the effect size in population-based samples is still missing. Only data from the US population random sample of NHANES III (n ¼ 16000, conducted in 1988-1994) , where cotinine was measured in blood, have been used for multivariate modelling of potential influences on blood cotinine levels (Pirkle et al., 1996) .
In NHANES III, which included children and babies, cotinine could be detected in serum in 88% of the nonsmoking subjects, but the results cannot directly be compared with our study results due to the different ages of the populations and methodological differences between both studies. In NHANES III, 37.4% of adult nonsmokers reported exposure to ETS at home or at work which is approximately twice the number in GerES III. However, GerES was conducted about 10 years later than NHANES III and the decrease in smoking prevalence in Germany and the national regulations for better protection against tobacco smoke exposure have to be considered when results of both surveys are compared. The NHANES III data showed statistically significant effect estimates for the number of smokers in the household and the number of hours of ETS exposure at work (Pirkle et al., 1996) . However, effect sizes in both studies could not be compared because the NHANES III data were analysed using linear regression techniques although the outcome cotinine was not detectable in approximately 12% of the non-tobacco users.
Dietary Factors
Several authors have argued against the validity and specificity of nicotine and cotinine as biomarkers for ETS exposure (Davis et al., 1991; Domino et al., 1993; Domino, 1995) . The role of consumption of nicotine-containing foods such as tomatoes, potatoes, cabbage, green pepper and teas on nicotine and cotinine excretion has been controversially debated (Domino et al., 1993; Jarvis, 1994) . We did not identify any effect from nicotine-containing foods in the current GerES. Although other relevant food such as tomatoes and green pepper could not be considered because no specific data were available, the content of nicotine in these food items and the daily amount of consumption of these food items is too low to show any effects on nicotine and cotinine (Benowitz, 1996) . Jarvis (1994) calculated that an amount of 90 kg tomatoes per day has to be eaten in order to show nicotine levels on the same level as nonsmoking subjects who are exposed to ETS from two or more smoking family members at home.
Strengths and Limitations
The huge data set of this national population-based sample lead to stable and consistent estimates of the effect sizes of ETS exposuresFindependent of the coding method for the included variables, inclusion or exclusion of other potentially influential factors, and model adjustment for creatinine or the expression of the biomarker concentration per gram creatinine. It further allowed us to perform sensitivity analyses on smaller subgroups. The results seem biologically plausible with regard to the main effects of interest, and also for the effect estimates for the confounding factors that could not be discussed here for brevity reasons. The lower sensitivity of urine tests compared to blood tests of nicotine and cotinine is a limiting factor that might have hidden influential factors other than tobacco smoke. Furthermore, the effect sizes of ETS exposure might have been underestimated. A categorization of the study population in smokers and nonsmokers using self-reported data on smoking might misclassify smokers as nonsmokers. The misclassification rate was assessed to 1-2% for smokers of the German adult population (Keil et al., 1999; Heller et al., 1998) . However, the effect estimates only marginally changed when the ''self-reported'' nonsmoking subjects with extremely high nicotine and cotinine excretions were excluded from the analyses. So, there was no indication of a strong bias of our results due to misclassification of smokers as nonsmokers. The goal of GerES III was to collect data on the body burden of several environmental pollutants including tobacco-derived agents. This survey was not explicitly designed to study factors influencing nicotine and cotinine excretion and therefore, the current study should be considered a secondary data analysis. Diary data on smoking and ETS exposure in the days before urine collection were not available. Including diary data might have presumably improved our model fit and the estimates for ETS-related effects. The participation rate in the GerES III was not high enough to rule out any participation bias. We assume that low participation might affect the validity of prevalence estimates. For the purpose of modelling effect sizes of ETS exposure on biomarkers we would think that a lower participation rate is not crucial for unbiased prevalence estimation.
Exposure of nonsmokers to ETS at home is quite common in Germany (approximately 25%, see Table 1 ). Nonsmokers who lived with one, or two or more smokers at home had a four or six-fold higher prevalence of detectable nicotine or cotinine excretion respectively than those who lived with only nonsmokers. Even more notable is the high proportion of nonsmokers exposed to ETS in the workplace since workplace ETS exposure doubled the risk of detection of nicotine and cotinine in urine.
Conclusion
Dietary intake of nicotine containing food was not identified as source of nicotine and cotinine excretion in urine in the German adult population. Tobacco smoke was the only source for these biomarkers.
Exposure to ETS in the workplace and in public places is still an important public health issue in Germany. While a new federal bill to diminish ETS exposure in the workplace was passed in 2002, regulation in other public places could further decrease ETS exposure. However, protection of nonsmokers from ETS at home also needs more attention.
